Why I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men.

scientific article

Why I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10461-018-2045-1
P8608Fatcat IDrelease_5jm7yundyff2ze653n55vltagy
P932PMC publication ID6077114
P698PubMed publication ID29404756

P50authorJeffrey T. ParsonsQ39673170
Steven A. JohnQ47135218
Jonathon RendinaQ57416823
Christian GrovQ60028371
P2093author name stringThomas H F Whitfield
P2860cites workPrejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidenceQ24680327
"Any other comments?" Open questions on questionnaires - a bane or a bonus to research?Q24798884
Preexposure prophylaxis for HIV prevention: where have we been and where are we going?Q26825042
Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV preventionQ30100960
Access to Basic HIV-Related Services and PrEP Acceptability among Men Who Have sex with Men Worldwide: Barriers, Facilitators, and Implications for Combination Prevention.Q30378507
Sexual Behavior, Sexual Attraction, and Sexual Orientation Among Adults Aged 18-44 in the United States: Data From the 2011-2013 National Survey of Family GrowthQ31036880
Preexposure prophylaxis and predicted condom use among high-risk men who have sex with menQ34012348
Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couplesQ34021932
Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study)Q34022009
PrEP awareness and perceived barriers among single young men who have sex with men.Q34124342
High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudyQ34681829
Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populationsQ34989216
"Is this normal? Is this not normal? There's no set example": Sexual Health Intervention Preferences of LGBT Youth in Romantic RelationshipsQ35064040
Accuracy of highly sexually active gay and bisexual men's predictions of their daily likelihood of anal sex and its relevance for intermittent event-driven HIV pre-exposure prophylaxisQ35102317
Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigmQ35780443
Willingness to Take PrEP and Potential for Risk Compensation Among Highly Sexually Active Gay and Bisexual Men.Q36029779
The critical role of intimacy in the sexual risk behaviors of gay and bisexual men.Q36036035
Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling NotesQ36118829
Recruiting a U.S. national sample of HIV-negative gay and bisexual men to complete at-home self-administered HIV/STI testing and surveys: Challenges and OpportunitiesQ36549464
Perceived likelihood of using HIV pre-exposure prophylaxis medications among young men who have sex with menQ36640005
No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice SettingQ36735089
From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City.Q36760768
Seasons of Risk: Anticipated Behavior on Vacation and Interest in Episodic Antiretroviral Pre-exposure Prophylaxis (PrEP) Among a Large National Sample of U.S. Men Who have Sex with Men (MSM).Q36863426
Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.Q36995428
Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after educationQ37137347
Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial ParticipantsQ38651723
Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States.Q38967290
Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men.Q39259966
Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP).Q40065272
Self-Perception of HIV Risk and Candidacy for Pre-Exposure Prophylaxis Among Men Who Have Sex with Men Testing for HIV at Commercial Sex Venues in New York CityQ40083596
Brief Report: PrEP Uptake, Adherence, and Discontinuation Among California YMSM Using Geosocial Networking ApplicationsQ40566237
A SWOT Analysis of the Updated National HIV/AIDS Strategy for the U.S., 2015-2020.Q41000388
Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men.Q43973762
Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: An opportunity to address barriers to PrEP uptake and persistenceQ48342302
Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?Q50075573
P921main subjectpre-exposure prophylaxis against HIVQ7239230
P577publication date2018-02-05
P1433published inAIDS and BehaviorQ15752229
P1476titleWhy I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men.

Reverse relations

cites work (P2860)
Q57282342Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California
Q90662882Elevated HIV Prevalence and Correlates of PrEP Use Among a Community Sample of Black Men Who Have Sex With Men
Q91778059Expanding Knowledge About Implementation of Pre-exposure Prophylaxis (PrEP): A Methodological Review
Q93005053Give PrEP a chance: moving on from the "risk compensation" concept
Q92918284Global implementation of PrEP for HIV prevention: setting expectations for impact
Q99622758Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies
Q91894502Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis
Q89415225Modelling the Epidemiological Impact and Cost-Effectiveness of PrEP for HIV Transmission in MSM in China
Q90709655Motives for choosing, switching and stopping daily or event-driven pre-exposure prophylaxis - a qualitative analysis
Q90507332Out-of-pocket costs and HIV pre-exposure prophylaxis persistence in a US multicity demonstration project
Q88715224Patterns and Correlates of Participant Retention in a Multi-City Pre-Exposure Prophylaxis Demonstration Project
Q61946146Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017
Q64111114Predictors of Disengagement in Care for Individuals Receiving Pre-Exposure Prophylaxis (PrEP)
Q59352212Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Pre-exposure Prophylaxis among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study
Q89505055Relationship Education and HIV Prevention for Young Male Couples Administered Online via Videoconference: Protocol for a National Randomized Controlled Trial of 2GETHER
Q57612456Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017

Search more.